Evaluating New-Onset Breathlessness in the Hospitalized Patient: A Practical Approach 

Dr Neeraj Manikath , claude.ai

Abstract

Breathlessness represents one of the most common and challenging presentations in hospital medicine, with a broad differential diagnosis spanning cardiovascular, pulmonary, hematologic, and systemic etiologies. This review provides a structured, evidence-based approach to evaluating new-onset dyspnea in hospitalized patients, highlighting diagnostic pearls, common pitfalls, and practical clinical hacks that can improve diagnostic accuracy and patient outcomes.

Introduction

Dyspnea affects approximately 20-30% of hospitalized medical patients and carries significant prognostic implications. The complaint of breathlessness activates an urgent diagnostic cascade, yet the non-specific nature of this symptom frequently leads to diagnostic delays, inappropriate investigations, and suboptimal management. This review synthesizes current evidence with practical clinical wisdom to guide the systematic evaluation of new-onset breathlessness in the inpatient setting.

The Initial Assessment: First Principles

The evaluation of acute dyspnea begins with simultaneous assessment and stabilization. While obtaining history and examination findings, ensure adequate oxygenation and hemodynamic stability. The initial vital signs provide crucial diagnostic clues often overlooked in the rush to advanced imaging.

Pearl: The "Vital Signs Diamond"

Four parameters assessed simultaneously can narrow your differential dramatically:

1. Oxygen saturation gradient: Compare room air saturation to supplemental oxygen response. Massive PE or right-to-left shunts show minimal improvement with supplemental oxygen, while most parenchymal lung disease responds appropriately.

2. Respiratory rate-to-distress concordance: Severe subjective dyspnea with normal respiratory rate (16-20/min) suggests metabolic acidosis, anxiety, or deconditioning. Conversely, tachypnea (>30/min) with minimal subjective distress may indicate chronic compensation.

3. Pulse-temperature relationship: Relative bradycardia with fever suggests atypical pneumonia or psittacosis. Marked tachycardia without fever points toward pulmonary embolism, cardiac causes, or thyrotoxicosis.

4. Positional variation: Platypnea-orthodeoxia (worsening with upright position) suggests hepatopulmonary syndrome, atrial septal defect with right-to-left shunt, or rarely, localized pulmonary arteriovenous malformations.

Hack: The "Two-Minute Rule"

Before ordering any investigation, invest two minutes in three simple maneuvers:

1. Forced expiratory time (FET): Have the patient take a deep breath and exhale forcefully with mouth open. FET >6 seconds suggests significant airflow obstruction (sensitivity 75%, specificity 85% for FEV1 <50% predicted).

2. Supine-to-sitting examination: Assess jugular venous pressure in both positions. A rise >3 cm in JVP when supine suggests volume overload, even when initial examination appears normal.

3. Single-breath counting test: Ask the patient to count from 1 as high as possible in a single breath. Inability to reach 15 suggests significant respiratory compromise (correlates with FEV1 <1.5L or vital capacity <50%).

History Taking: Beyond the Obvious

Oyster: The "Temporal Pattern Analysis"

The time course of symptom onset provides diagnostic gold:

• Seconds to minutes: Pneumothorax, pulmonary embolism, aspiration, arrhythmia, or airway obstruction
• Minutes to hours: Acute coronary syndrome, pulmonary edema, asthma exacerbation, or anaphylaxis
• Hours to days: Pneumonia, pleural effusion, or decompensated heart failure
• Days to weeks: Anemia, subacute PE, progressive malignancy, or interstitial lung disease

Fallacy: "Orthopnea Equals Heart Failure"

While orthopnea classically suggests heart failure, several other conditions produce positional dyspnea:

• Bilateral diaphragmatic paralysis (worse when supine due to abdominal contents pushing against paralyzed diaphragms)
• Severe GERD with microaspiration
• Massive ascites or obesity
• Superior vena cava syndrome
• Large pleural effusions (may improve with lying on affected side—"trepopnea")

Always correlate with other clinical features and objective findings.

Physical Examination: The Lost Art

Pearl: Cardiac Auscultation Nuances

The third heart sound (S3) remains one of the most specific signs of volume overload (specificity >90% for elevated left ventricular end-diastolic pressure), yet it's frequently missed. Optimize detection by:

• Examining with bell of stethoscope
• Patient in left lateral decubitus position
• Listening at apex during expiration
• Using simultaneous carotid pulse palpation for timing

An S3 heard at the left lower sternal border suggests right ventricular failure or volume overload—a critical distinction when considering PE versus heart failure.

Hack: The "Cachexia Sign"

In patients with chronic breathlessness of unclear etiology, assess for temporal muscle wasting, interosseous muscle loss, and deltoid atrophy. These signs of cardiac cachexia appear earlier than weight loss and predict poor prognosis in heart failure (hazard ratio 1.4-1.8 for mortality). Their presence should elevate your suspicion for advanced cardiac disease even when echocardiography shows preserved ejection fraction.

Oyster: Lower Extremity Examination Beyond Edema

Examine for:

• Unilateral calf tenderness/swelling: DVT (but absent in 50% of PE cases)
• Erythema nodosum: Consider sarcoidosis, tuberculosis, or connective tissue disease
• Digital clubbing: Suggests interstitial lung disease, malignancy, or endocarditis
• Severe peripheral edema with normal JVP: Think albumin loss (nephrotic syndrome, cirrhosis) rather than heart failure

Diagnostic Investigations: Choosing Wisely

The Indispensable Triad

Three initial tests provide maximum diagnostic yield:

1. Arterial Blood Gas Analysis

An ABG provides information no other single test can:

• A-a gradient calculation distinguishes intrapulmonary from extrapulmonary causes
• pH reveals metabolic acidosis driving respiratory compensation
• PaCO2 level indicates adequacy of ventilation

Pearl: An A-a gradient <10 mmHg essentially excludes significant parenchymal lung disease or PE. Calculate using: A-a gradient = (FiO2 × [Patm - PH2O] - PaCO2/0.8) - PaO2. At sea level on room air, this simplifies to: (150 - PaCO2/0.8) - PaO2.

2. B-Type Natriuretic Peptide (BNP) or NT-proBNP

BNP <100 pg/mL or NT-proBNP <300 pg/mL effectively rules out acute heart failure (negative predictive value >90%). However, multiple conditions elevate BNP independently of heart failure:

• Advanced age (increase by ~10% per decade after age 55)
• Renal dysfunction (NT-proBNP more affected than BNP)
• Atrial fibrillation (may double baseline levels)
• Pulmonary embolism (often >500 pg/mL with right ventricular strain)
• Sepsis and critical illness

Hack: In the "gray zone" (BNP 100-400 pg/mL or NT-proBNP 300-1800 pg/mL), obtain a chest radiograph and calculate BNP/troponin ratio. A ratio <10 favors heart failure, while >30 suggests alternative diagnoses, particularly in the context of right ventricular strain.

3. High-Sensitivity Troponin

Even minor elevations provide prognostic information across multiple conditions causing dyspnea. Serial measurements (0 and 3 hours) using validated algorithms (ESC 0/1-hour or 0/3-hour protocols) reliably exclude acute coronary syndrome.

Fallacy: "Normal D-Dimer Rules Out PE"

While age-adjusted D-dimer cutoffs (age × 10 μg/L for patients >50 years) improve specificity without sacrificing sensitivity, several caveats apply:

• D-dimer has limited utility in hospitalized patients due to high false-positive rates (inflammatory states, malignancy, recent surgery, advanced age)
• In high pretest probability scenarios (Wells score >4 or revised Geneva score >10), proceed directly to imaging regardless of D-dimer
• Fibrinogen levels <100 mg/dL may yield false-negative D-dimers in catastrophic PE

Pearl: In suspected PE with contraindications to CT angiography (severe contrast allergy, renal dysfunction), consider lower extremity venous ultrasound first. A positive study establishes need for anticoagulation without CT exposure. However, negative ultrasound doesn't exclude PE, as only 30-50% of PE patients have detectable DVT.

Imaging Strategy: A Stepwise Approach

Chest Radiography: The Gateway Investigation

Despite advanced imaging availability, chest X-ray remains invaluable for:

• Detecting pneumothorax, consolidation, or massive pleural effusion
• Identifying cardiac silhouette enlargement (cardiothoracic ratio >0.5)
• Recognizing pulmonary edema patterns (cephalization, Kerley B lines, perihilar infiltrates)
• Discovering unsuspected masses or hilar lymphadenopathy

Oyster: Three subtle radiographic signs deserve special attention:

1. Westermark sign (focal oligemia) in PE—present in <10% but highly specific
2. Hampton's hump (wedge-shaped peripheral opacity) in PE—pathognomonic when present
3. Palla's sign (enlarged right descending pulmonary artery) suggests massive PE

Computed Tomography: When and What?

CT Pulmonary Angiography (CTPA): First-line for suspected PE in patients with moderate-to-high pretest probability. Sensitivity and specificity both exceed 95% for main, lobar, and segmental PE. Subsegmental PE detection remains controversial—clinical significance uncertain, particularly when isolated.

High-Resolution CT Chest: Reserved for suspected interstitial lung disease, particularly when:

• Basilar crackles present on examination
• Restrictive pattern on bedside spirometry
• Clinical context suggests systemic disease (connective tissue disorders, drug reactions, occupational exposures)

Hack: Before ordering CTPA, ensure adequate timing. Contrast injection-to-scan delay significantly affects diagnostic accuracy. Suboptimal studies (poor contrast opacification) approach 5-10% and require repeat imaging. Discuss with radiology for patients with poor cardiac output, obesity, or difficult venous access.

Echocardiography: Beyond Ejection Fraction

Transthoracic echocardiography provides crucial information beyond systolic function:

Key Parameters in Dyspnea Evaluation

Diastolic function assessment: Up to 50% of heart failure patients have preserved ejection fraction (HFpEF). Evaluate using:

• E/A ratio (early/late diastolic filling)
• E/e' ratio (early diastolic tissue velocity)
• Left atrial volume index
• Tricuspid regurgitation velocity

Pearl: E/e' ratio >14 indicates elevated left ventricular filling pressures with high specificity. Combined with elevated BNP, this confirms HFpEF even with normal ejection fraction.

Right ventricular assessment: Essential in suspected PE or pulmonary hypertension. Signs of right ventricular strain include:

• RV dilation (RV:LV ratio >1.0)
• Reduced tricuspid annular plane systolic excursion (TAPSE <16 mm)
• McConnell's sign (RV free wall hypokinesis with apical sparing—specific for PE)
• Elevated right ventricular systolic pressure (>40 mmHg at rest)

Fallacy: "Normal Ejection Fraction Excludes Heart Failure"

HFpEF accounts for 50% of heart failure cases and carries similar mortality to reduced ejection fraction heart failure. Diagnosis requires:

1. Signs/symptoms of heart failure
2. Elevated natriuretic peptides
3. Evidence of cardiac structural/functional abnormality (left atrial enlargement, LV hypertrophy, diastolic dysfunction)
4. Exclusion of alternative diagnoses

Special Situations and Diagnostic Dilemmas

The Patient with "Normal" Initial Workup

When initial investigations fail to reveal a diagnosis:

Reassess for uncommon causes:

• Occult anemia (obtain complete blood count if not done)
• Metabolic acidosis (review ABG, calculate anion gap)
• Neuromuscular weakness (bedside negative inspiratory force measurement)
• Thyroid dysfunction (TSH, free T4)
• Carbon monoxide poisoning (carboxyhemoglobin level)

Hack: The "bedside exercise test"—have stable patients walk 50 feet or climb one flight of stairs under observation. Marked desaturation (>4% drop) or excessive tachycardia (>30 bpm increase) suggests significant cardiopulmonary limitation requiring further evaluation, even when resting parameters appear normal.

Distinguishing Cardiac from Pulmonary Causes

No single finding perfectly discriminates, but several features help:

Favor cardiac:

• Orthopnea and paroxysmal nocturnal dyspnea
• Elevated JVP and S3 gallop
• Peripheral edema with clear lung fields
• BNP >400 pg/mL
• Cardiomegaly on chest X-ray

Favor pulmonary:

• History of smoking or occupational exposures
• Productive cough or hemoptysis
• Wheezing or prolonged expiratory phase
• Normal cardiac examination
• Infiltrates or hyperinflation on imaging

Oyster: When both cardiac and pulmonary disease coexist (common in elderly patients), prioritize treating the most immediately life-threatening condition first. Acute pulmonary edema with respiratory failure requires immediate diuresis and non-invasive ventilation. Conversely, massive PE with hemodynamic instability necessitates anticoagulation or thrombolysis before addressing concurrent heart failure.

Avoiding Cognitive Biases

Several cognitive pitfalls compromise diagnostic accuracy:

Anchoring bias: Fixating on initial working diagnosis despite contradictory evidence. Combat this by systematically reconsidering the differential when patients don't respond as expected to treatment.

Availability bias: Overweighting recent experiences or dramatic cases. PE isn't always the answer, despite memorable cases.

Premature closure: Accepting the first plausible diagnosis without considering alternatives. Always ask, "What else could this be?"

Hack: Use a mental checklist for every dyspneic patient—"Could this be PE, ACS, heart failure, pneumonia, or COPD exacerbation?" Explicitly consider and document why you're excluding each major diagnosis.

Conclusion

Evaluating new-onset breathlessness requires systematic integration of clinical assessment, strategic investigation, and awareness of diagnostic pitfalls. Success depends on recognizing patterns, avoiding cognitive biases, and maintaining diagnostic humility. The approaches outlined here—combining evidence-based medicine with practical clinical wisdom—provide a framework for accurate, efficient diagnosis in the complex hospitalized patient.

Key takeaways:

• Vital signs provide critical early diagnostic clues
• Physical examination retains diagnostic value despite advanced imaging
• Strategic test selection improves diagnostic efficiency
• Awareness of cognitive biases prevents diagnostic errors
• Multiple conditions frequently coexist in hospitalized patients

Mastery of dyspnea evaluation separates competent from exceptional internists. By applying these principles, clinicians can improve diagnostic accuracy, reduce unnecessary testing, and ultimately enhance patient outcomes.

References

1. Berliner D, Schneider N, Welte T, Bauersachs J. The differential diagnosis of dyspnea. Dtsch Arztebl Int. 2016;113(49):834-845.

2. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435-452.

3. Mueller C, McDonald K, de Boer RA, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715-731.

4. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2020;41(4):543-603.

5. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726.

6. Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199(11):1368-1376.

7. Mahler DA, Selecky PA, Harrod CG, et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010;137(3):674-691.

8. Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117-1124.